Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach
- 9 December 2003
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 33 (3) , 140-154
- https://doi.org/10.1016/j.semarthrit.2003.09.002
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: Lack of evidence for a direct role of lamin B1 in apoptotic blebsArthritis & Rheumatism, 2002
- Long‐term followup of children with neonatal lupus and their unaffected siblingsArthritis & Rheumatism, 2002
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Pituitary-Adrenal Response in Preterm Very Low Birth Weight Infants after Treatment with Antenatal CorticosteroidsJournal of Clinical Endocrinology & Metabolism, 1997
- Neonatal lupus erythematosus: Discordant disease expression of U1RNP-positive antibodies in fraternal twins—Is this a subset of neonatal lupus erythematosus or a new distinct syndrome?Journal of the American Academy of Dermatology, 1995
- Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Cardiovascular manifestations of Lyme diseaseAmerican Heart Journal, 1991
- Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trialThe Journal of Pediatrics, 1989
- Connective-Tissue Disease, Antibodies to Ribonucleoprotein, and Congenital Heart BlockNew England Journal of Medicine, 1983
- The transplacental passage of prednisone and prednisolone in pregnancy near termThe Journal of Pediatrics, 1972